ArticleJACC. Case reports2026
MRCA Combined With Zero-Contrast IVUS-Guided PCI in a Patient With NSTE-ACS and Severe Contrast Allergy.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Case Report: Zero-contrast multivessel PCI with left main bifurcation guided by dual IVUS strategies using a coronary CTA roadmap.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe management of acute coronary syndrome in patients with severe hypersensitivity reactions to iodine-based contrast media (ICM) remains a considerable clinical challenge, particularly when coronary anatomy is undetermined. CASE SUMMARY: A 50-year-old man with non-ST-segment elevation acute coronary syndrome and severe hypersensitivity reactions to ICM was referred for revascularization without coronary anatomic information. Magnetic resonance coronary angiography (MRCA) and zero-contrast intravascular ultrasound (IVUS) were integrated for the first time to evaluate coronary artery lesions and guide percutaneous coronary intervention. DISCUSSION: This case demonstrates that combining MRCA with IVUS-guided percutaneous coronary intervention presents a promising direction for managing patients with coronary artery disease who experience hypersensitivity reactions to ICM. This is especially beneficial for high-risk patients who require revascularization. TAKE-HOME MESSAGE: Multimodality imaging strategy, which integrates MRCA and IVUS, provides a viable solution to such clinical challenges, thereby enabling revascularization in patients with coronary artery disease and specific contraindications to conventional imaging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.